{"url_path":"/sec/rtgn/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1836295/0001493152-26-024649-index.html","accession_number":"0001493152-26-024649","cik":"0001836295","ticker":"RTGN","issuer_name":"RetinalGenix Technologies Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1836295/0001493152-26-024649-index.html","primary_entity_key":"0001836295","primary_entity_name":"RetinalGenix Technologies Inc."},"word_count":277,"has_tables":true,"body_markdown":"**ITEM\n6. EXHIBITS.**\n\n \n\n**Exhibit**\n\n**No.**\n\n \n**Description**\n\n \n \n \n\n3.1\n \n[First Amended and Restated Certificate of Incorporation of RetinalGenix Technologies Inc. (Incorporated by reference to Exhibit 3.1 the Company’s Registration Statement on Form S-1 filed with the SEC on August 5, 2021)](https://www.sec.gov/Archives/edgar/data/1836295/000149315221018775/ex3-1.htm)\n\n \n \n \n\n3.2\n \n[Bylaws of RetinalGenix Technologies Inc. (Incorporated by reference to Exhibit 3.2 the Company’s Registration Statement on Form S-1 filed with the SEC on August 5, 2021)](https://www.sec.gov/Archives/edgar/data/1836295/000149315221018775/ex3-2.htm)\n\n \n \n \n\n31.1*\n \n[Certification of Principal Executive Officer and Principal Financial and Accounting Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm)\n\n \n \n \n\n32.1*\n \n[Certification of Principal Executive Officer and Principal Financial and Accounting Officer pursuant to Rule 13(a)-14(b) of the Securities Exchange Act of 1934, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n\n \n \n \n\n101.INS*\n \nInline\nXBRL Instance Document\n\n \n \n \n\n101.SCH*\n \nInline\nXBRL Taxonomy Extension Schema Document\n\n \n \n \n\n101.CAL*\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document\n\n \n \n \n\n101.DEF*\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document\n\n \n \n \n\n101.LAB*\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document\n\n \n \n \n\n101.PRE*\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document\n\n \n \n \n\n104*\n \nCover\nPage Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March\n31, 2025 is formatted in Inline XBRL\n\n \n\n*\nFiled\nherewith.\n\n \n\n24\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf\nby the undersigned thereunto duly authorized.\n\n \n\n \n**RETINALGENIX\nTECHNOLOGIES INC.**\n\n \n \n\nDate:\nMay 20, 2026\nBy:\n*/s/\nJerry Katzman*\n\n \n \nJerry\nKatzman,\n\n \n \nChief\nExecutive Officer, President and Interim Chief Financial Officer (Principal Executive Officer and Principal Financial and Accounting\nOfficer)\n\n \n\n25"}